Kazuteru Aoki
Vice President, Biology FIMECS
Kazuteru Aoki is leading the operations of biological research activities as a vice president of biology. He has experience in platform establishment and drug discovery in biotech companies throughout his 20-year career. At FIMECS, he has contributed to establishing their proprietary degrader discovery platform and identifying novel E3 ligases.
Seminars
Thursday 30th October 2025
Unlocking Novel E3 Ligases with an E3-Agnostic Discovery Platform to Expand Degrader Space
2:30 pm
- Leveraging the RaPPIDSTM platform to accelerate degrader discovery via high-throughput synthesis and phenotypic screening
- Identifying and functionally characterizing proprietary ligands that engage underexplored E3 ligases
- Enabling expansion of E3 ligase usage to unlock new biological space and accelerate pipeline progression
